Research Highlights Expanded Clinical Uses of SGLT2 Inhibitors Medha Baranwal6 Jan 2025 8:30 AM ISTUSA: A recent editorial published in the Journal of Cardiothoracic and Vascular Anesthesia highlights the growing clinical applications of...
Empagliflozin has potential of lowering progression of Diabetic Retinopathy among diabetes patients: Study Dr.Niharika Harsha B6 Dec 2024 8:45 PM ISTA recent study published in the journal JAMA Ophthalmology found that empagliflozin was associated with a reduced risk of the progression of...
Case of Euglycemic Diabetic Ketoacidosis due to SGLT2 inhibitor Empagliflozin Dr.Niharika Harsha B6 Nov 2024 9:30 AM ISTA recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ketoacidosis (EDKA) with...
Lupin Gets CDSCO Panel Nod to Study Antidiabetic FDC Dr. Divya Colin1 Nov 2024 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Empagliflozin and Topiramate combo Effective for Weight Loss in Non-Diabetic Overweight Individuals: Study Medha Baranwal21 Oct 2024 8:15 AM ISTIran: A recent randomized study revealed that the combination of empagliflozin (EMPA) and topiramate (TPM) alongside calorie restriction resulted in a...
SGLT2 inhibitor empagliflozin safe and effective for treating patients who have suffered MI: EMPACT-MI, ESC 2024 Dr. Kamal Kant Kohli3 Sept 2024 10:30 AM ISTThe SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Empagliflozin plus Sitagliptin FDC Dr. Divya Colin28 Aug 2024 6:15 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
SGLT2 inhibitors reduce arrhythmias risk in patients with type 2 diabetes: BMC study Jacinthlyn Sylvia12 July 2024 9:30 AM ISTA new study published in the recent issue of BMC Cardiovascular Diabetology journal found that in individuals with type 2 diabetes who...
Lupin secures USFDA tentative nod for Empagliflozin, Linagliptin and Metformin Hydrochloride ER tablets Ruchika Sharma10 July 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
Empagliflozin Use Leads to Rare Case of Emphysematous Cystitis in Non-Diabetic Patient: Case Study Medha Baranwal8 July 2024 8:30 AM ISTMalta: A recent case study published in Cureus Journal has described a rare medical case in which the use of empagliflozin, a medication typically...
Glyceraldehyde derivatives inspired by empagliflozin potential anti-heart failure agents independent of glucose-lowering effects: Study Dr. Kamal Kant Kohli16 May 2024 8:15 AM ISTHeart failure (HF) is a complex clinical syndrome characterized by high mortality and frequent hospitalizations. HF significantly affected the quality...
Empagliflozin Shows Promise for Alleviating Peripheral Diabetic Neuropathy in Type 2 Diabetes Patients: Study Medha Baranwal7 May 2024 10:00 AM ISTEgypt: In a significant development for type 2 diabetes mellitus (T2DM) management, a recent study has uncovered promising evidence regarding the...
